Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro
- PMID: 22967103
- PMCID: PMC3442934
- DOI: 10.1111/j.1365-2893.2012.01595.x
Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro
Abstract
Occult hepatitis B virus (HBV) infection is characterized by the absence of detectable hepatitis B surface antigen (HBsAg) in the serum, despite detectable HBV DNA. Investigations of the mechanisms underlying the development of occult HBV infection are lacking in the current literature, although viral mutations in the surface region, resulting in decreased HBsAg expression or secretion, represent one potential mechanism. Wild-type HBsAg expression vectors were constructed from genotype-matched chronic HBV sequences. Site-directed mutagenesis was then utilized to introduce three genotype A mutations - M103I, K122R and G145A - associated with occult HBV infection in vivo, alone and in combination, into the wild-type HBsAg vectors. Transfection of Huh7 and HepG2 cell lines was performed, and cell culture supernatants and cell lysates were collected over 7 days to assess the effects of these mutations on extracellular and intracellular HBsAg levels. The G145A mutation resulted in significantly decreased extracellular and intracellular HBsAg expression in vitro. The most pronounced reduction in HBsAg expression was observed when all three mutations were present. The mutations evaluated in vitro in the current study resulted in decreased HBsAg expression and potentially increased hepatic retention and/or decreased hepatic secretion of synthesized HBsAg, which could explain the lack of HBsAg detection that is characteristic of occult HBV infection in vivo.
© 2012 Blackwell Publishing Ltd.
Figures


Similar articles
-
Identification and characteristics of mutations promoting occult HBV infection by ultrasensitive HBsAg assay.J Clin Microbiol. 2025 May 14;63(5):e0207124. doi: 10.1128/jcm.02071-24. Epub 2025 Mar 31. J Clin Microbiol. 2025. PMID: 40162819 Free PMC article.
-
Novel hepatitis B virus surface antigen mutations associated with occult genotype B hepatitis B virus infection affect HBsAg detection.J Viral Hepat. 2020 Sep;27(9):915-921. doi: 10.1111/jvh.13309. Epub 2020 May 11. J Viral Hepat. 2020. PMID: 32336003
-
Mutations associated with occult hepatitis B in HIV-positive South Africans.J Med Virol. 2015 Mar;87(3):388-400. doi: 10.1002/jmv.24057. Epub 2014 Aug 27. J Med Virol. 2015. PMID: 25164924 Free PMC article.
-
Association of preS/S Mutations with Occult Hepatitis B Virus (HBV) Infection in South Korea: Transmission Potential of Distinct Occult HBV Variants.Int J Mol Sci. 2015 Jun 15;16(6):13595-609. doi: 10.3390/ijms160613595. Int J Mol Sci. 2015. PMID: 26084041 Free PMC article. Review.
-
Molecular mechanisms underlying HBsAg negativity in occult HBV infection.Eur J Clin Microbiol Infect Dis. 2015 Sep;34(9):1709-31. doi: 10.1007/s10096-015-2422-x. Epub 2015 Jun 24. Eur J Clin Microbiol Infect Dis. 2015. PMID: 26105620 Review.
Cited by
-
Incidence of Occult Hepatitis B Infection (OBI) and hepatitis B genotype characterization among blood donors in Cameroon.PLoS One. 2024 Oct 16;19(10):e0312126. doi: 10.1371/journal.pone.0312126. eCollection 2024. PLoS One. 2024. PMID: 39413100 Free PMC article.
-
Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana.Genes (Basel). 2018 Sep 7;9(9):453. doi: 10.3390/genes9090453. Genes (Basel). 2018. PMID: 30205537 Free PMC article.
-
Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor-Sparing Antiretroviral Therapy in a High-HBV Endemicity Setting.Open Forum Infect Dis. 2018 Oct 5;5(10):ofy251. doi: 10.1093/ofid/ofy251. eCollection 2018 Oct. Open Forum Infect Dis. 2018. PMID: 30377627 Free PMC article.
-
Role of S protein transmembrane domain mutations in the development of occult hepatitis B virus infection.Emerg Microbes Infect. 2022 Dec;11(1):2184-2196. doi: 10.1080/22221751.2022.2114849. Emerg Microbes Infect. 2022. PMID: 35976035 Free PMC article.
-
HBsAg may reappear following reactivation in individuals with spontaneous HBsAg seroclearance 8 years previously.Epidemiol Infect. 2017 Mar;145(4):728-738. doi: 10.1017/S095026881600279X. Epub 2016 Dec 5. Epidemiol Infect. 2017. PMID: 27917751 Free PMC article.
References
-
- Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of Viral Hepatitis. 2004;11(2):97–107. - PubMed
-
- Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45(2):507–39. - PubMed
-
- Bodsworth NJ, Cooper DA, Donovan B. The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state. Journal of Infectious Diseases. 1991;163(5):1138–40. - PubMed
-
- Jilg W, Sieger E, Zachoval R, Schatzl H. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. Journal of Hepatology. 1995;23(1):14–20. - PubMed
-
- Shire NJ, Rouster SD, Stanford SD, et al. The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes. 2007;44(3):309–14. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical